Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

The New England journal of medicine·2026
Same author

Novel KIF22 Variants Disrupt Mitosis in Human Chondrocytes and Expand SEMDJL2 Mechanisms.

Molecular biology of the cell·2026
Same author

A next-generation episignature for Kabuki syndrome enables fine mapping of the impact of KMT2D variants to inform precision medicine.

American journal of human genetics·2026
Same author

Evaluating the impact of vosoritide on complications of achondroplasia.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Novel KIF22 Variants Disrupt Mitosis in Human Chondrocytes and Expand SEMDJL2 Mechanisms.

bioRxiv : the preprint server for biology·2026
Same author

Effect of vosoritide on spine morphology in children with achondroplasia: 1-year results from a randomized phase 2 study.

Journal of the Endocrine Society·2026

Related Experiment Video

Updated: Jun 4, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Clinical phenotypes associated with type II collagen mutations.

Peter Kannu1, John Bateman, Ravi Savarirayan

  • 1Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada. peter.kannu@sickkids.ca

Journal of Paediatrics and Child Health
|February 22, 2011
PubMed
Summary

Mutations in the COL2A1 gene cause a range of skeletal and cartilage disorders. Recognizing this genetic link aids in early diagnosis and management of bone and joint diseases.

More Related Videos

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools
07:58

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Published on: November 11, 2020

Related Experiment Videos

Last Updated: Jun 4, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools
07:58

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Published on: November 11, 2020

Area of Science:

  • Genetics
  • Orthopedics
  • Molecular Biology

Background:

  • Mutations in the COL2A1 gene lead to a spectrum of skeletal and cartilage disorders, varying from lethal conditions to milder phenotypes.
  • Recognized features include short stature, eye, palate, and hearing abnormalities, but presentation variability is often underestimated.
  • COL2A1 mutations can present solely as joint disease, without other typical phenotypic indicators.

Purpose of the Study:

  • To investigate the hypothesis that COL2A1 mutations cause novel phenotypes, including premature arthritis and severe bone dysplasias.
  • To highlight the diagnostic significance of identifying COL2A1 mutations for risk assessment and natural history understanding.
  • To emphasize the importance of early identification for preventative strategies and management of related musculoskeletal conditions.

Main Methods:

  • Review of clinical data and genetic testing results for individuals with suspected COL2A1-related disorders.
  • Phenotypic analysis correlating specific COL2A1 mutations with clinical presentations.
  • Literature review to consolidate understanding of the phenotypic spectrum.

Main Results:

  • Confirmed significant variability in COL2A1 mutation phenotypes, including presentations not typically associated with type II collagen disorders.
  • Identified cases where COL2A1 mutations manifested primarily as early-onset joint disease.
  • Demonstrated a spectrum from mild chondrodysplasias to severe bone dysplasias linked to COL2A1 mutations.

Conclusions:

  • COL2A1 mutations are associated with a broader range of skeletal and joint diseases than previously recognized.
  • Accurate identification of COL2A1 mutations is crucial for precise diagnosis, recurrence risk assessment, and tailored patient management.
  • Early intervention strategies informed by genetic diagnosis can improve outcomes and potentially reduce healthcare costs for musculoskeletal conditions.